Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 06 Jan 2026 for Avenue Therapeutics, INC.. Read the official filing
Filing timeline
BuySaleFortress Biotech, Inc.
Insider track record
Disclosed buys
1
Disclosed sells
1
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Fortress Biotech, Inc.: trading record in brief
Fortress Biotech, Inc. has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Checkpoint Therapeutics, Inc., Avenue Therapeutics, Inc. and Mustang Bio, Inc. Between 12 May 2022 and 2 January 2026, the trades on record add up to 24 filings.
Both buying and selling appear: 1 purchase worth €282k, against 1 sale worth €113k. The net balance comes to €168k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 21 share grants.
On 6 January 2026 came the latest disclosure, a share grant in Avenue Therapeutics, Inc. The last insider purchase was made public on 12 September 2023, 1,132 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Fortress Biotech, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
111,209 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001429260-26-000004:0
278,385 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001429260-26-000002:0
59,334 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001429260-25-000004:0
100,000 shares@ US$1.29100.0% of flowCOMMON STOCK, PAR VALUE $0.0001SEC:0001415889-25-015470:0
33,724 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001415889-25-009621:0
67,806 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001415889-25-009620:0
18,500 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001415889-25-005849:0
81,407 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001415889-25-000403:0
146,341 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001415889-24-024182:0
575,191 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-24-076298:0
50,000 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-24-067324:0
413,507 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-24-048303:0
193,905 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-24-037986:0
158,134 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-24-000856:0
419,092 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-24-000859:0
2,101,496 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-24-000853:0
80,906 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-103872:0
418,410 shares@ US$0.72100.0% of flowCommon StockSEC:0001437749-23-025640:0
Canonical exit: 7 Dec 2023 (T+90)
81,406 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-077533:0
52,419 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-041491:0
35,714 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-041488:0
2,807,008 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-001929:0
368,907 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-001925:0
90,909 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-000998:0
24 of 24 declarations
